We are live on ! Find out more
GCM

Glenview Capital Management Portfolio holdings

AUM $5.49B
1-Year Est. Return 46.89%
This Fund
S&P 500
This Quarter Est. Return
-5.32%
1 Year Est. Return
+46.89%
3 Year Est. Return
+94.27%
5 Year Est. Return
+129.04%
10 Year Est. Return
+529.98%
AUM
$5.08B
AUM Growth
-$638M
Cap. Flow
-$133M
Cap. Flow %
-2.61%
Top 10 Hldgs %
62.65%
Holding
54
New
9
Increased
13
Reduced
20
Closed
6
Avg Time Held Equity + Options
10.1 quarters
Top 10 Avg Time Held Equity + Options
8.6 quarters
Top 20 Avg Time Held Equity + Options
7.8 quarters
Avg Time Held Equity only
10.4 quarters
Top 10 Avg Time Held Equity only
11.3 quarters
Top 20 Avg Time Held Equity only
8.3 quarters

Top Buys

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$467M
2
CNC icon
Centene
CNC
+$104M
3
GPN icon
Global Payments
GPN
+$80.4M
4
WCC icon
WESCO International
WCC
+$65M
5
CAR icon
Avis
CAR
+$39.1M

Top Sells

Rank Stock Value
1
THC icon
Tenet Healthcare
THC
+$200M
2
UHS icon
Universal Health Services
UHS
+$154M
3
FISV icon
Fiserv Inc
FISV
+$113M
4
CTVA icon
Corteva
CTVA
+$94.4M
5
DXC icon
DXC Technology
DXC
+$76.6M

Sector Composition

Rank Sector Weight
1 Healthcare 51.66%
2 Technology 14.48%
3 Industrials 10.25%
4 Materials 8.76%
5 Miscellaneous 7.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
THC icon
1
Tenet Healthcare
THC
$21.5B
$621M 12.22%
4,665,733
-1,661,470
-26% -$200M
2013 Q2
44 quarters
CVS icon
2
CVS Health
CVS
$112B
$541M 10.65%
9,162,389
+7,465,959
+440% +$467M
2023 Q4
2 quarters
CI icon
3
Cigna
CI
$74.7B
$428M 8.42%
1,293,799
-177,776
-12% -$61.3M
2013 Q2
44 quarters
GPN icon
4
Global Payments
GPN
$21.7B
$302M 5.93%
3,118,320
+730,098
+31% +$80.4M
2020 Q4
14 quarters
CTVA icon
5
Corteva
CTVA
$8.91B
$274M 5.39%
5,072,456
-1,713,817
-25% -$94.4M
2019 Q4
18 quarters
IWM icon
6
PUT
iShares Russell 2000 ETF
IWM
$77.9B
$234M 4.6%
1,152,100
-3,200
-0.3% -$647K
2023 Q2
4 quarters
ALIT icon
7
Alight
ALIT
$243M
$228M 4.48%
1,542,789
+126,545
+9% +$21.1M
2022 Q3
7 quarters
UHS icon
8
Universal Health Services
UHS
$10.6B
$219M 4.31%
1,184,295
-870,253
-42% -$154M
2022 Q4
6 quarters
ESI icon
9
Element Solutions
ESI
$9.07B
$172M 3.38%
6,326,903
-2,031,746
-24% -$50M
2016 Q3
31 quarters
DXC icon
10
DXC Technology
DXC
$2.04B
$166M 3.27%
8,706,739
-4,076,295
-32% -$76.6M
2017 Q2
28 quarters
MCK icon
11
McKesson
MCK
$112B
$155M 3.05%
265,717
-22,244
-8% -$12.4M
2016 Q4
30 quarters
TEVA icon
12
Teva Pharmaceutical Industries Limited
TEVA
$48.1B
$149M 2.93%
9,157,641
+1,656,357
+22% +$25.5M
2023 Q4
2 quarters
CLVT icon
13
Clarivate
CLVT
$1.02B
$146M 2.87%
25,651,317
+1,000,000
+4% +$6.38M
2022 Q2
8 quarters
USFD icon
14
US Foods
USFD
$21.2B
$132M 2.6%
2,494,887
-29,281
-1% -$1.54M
2021 Q4
10 quarters
SPY icon
15
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$822B
$127M 2.49%
232,900
-427,100
-65% -$224M
2024 Q1
1 quarter
CNC icon
16
Centene
CNC
$34B
$94.9M 1.87%
+1,431,312
New +$104M
2024 Q2
0 quarters
MYGN icon
17
Myriad Genetics
MYGN
$390M
$91.7M 1.8%
3,748,432
-1,195,163
-24% -$26.2M
2019 Q3
19 quarters
UBER icon
18
Uber
UBER
$146B
$87M 1.71%
1,197,173
+68,359
+6% +$4.75M
2021 Q2
12 quarters
EXPE icon
19
Expedia Group
EXPE
$32.8B
$75.5M 1.49%
599,438
-15,000
-2% -$1.85M
2022 Q3
7 quarters
KNX icon
20
Knight Transportation
KNX
$10.3B
$72.6M 1.43%
1,454,647
+129,586
+10% +$6.34M
2023 Q1
5 quarters
VTRS icon
21
Viatris
VTRS
$19.8B
$69M 1.36%
6,494,782
+1,352,783
+26% +$14.9M
2023 Q4
2 quarters
AMZN icon
22
Amazon
AMZN
$2.79T
$67.7M 1.33%
350,429
-52,513
-13% -$9.65M
2023 Q1
5 quarters
HCA icon
23
HCA Healthcare
HCA
$99.8B
$62.8M 1.24%
195,585
– –
2013 Q2
44 quarters
WCC icon
24
WESCO International
WCC
$17.7B
$60.5M 1.19%
+381,766
New +$65M
2024 Q2
0 quarters
MRVL icon
25
Marvell Technology
MRVL
$242B
$60.3M 1.19%
862,675
-507,929
-37% -$35.6M
2023 Q4
2 quarters
1
2 3

Similar funds

GCM
Graham Capital Management Rowayton, Connecticut $5.5B AUM 26.66% 1-Year Est. Return
VCM
Voleon Capital Management Berkeley, California $5.49B AUM 56.94% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
MC
Maplelane Capital New York $5.51B AUM 67.92% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
NC
Nicholas Company Milwaukee, Wisconsin $5.47B AUM 16.96% 1-Year Est. Return
EI
EFG International Zurich $5.46B AUM
AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return

Glenview Capital Management's Q2 2024 Portfolio in Review

As of Q2 2024, Glenview Capital Management held 54 positions worth $5.08B, down 11% from $5.72B the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Glenview Capital Management's Q2 2024 filing shows 9 new, 13 increased, 20 reduced and 6 closed positions. Its largest new stake was Centene: 1,431,312 shares worth $94.9M. The largest sale was Tenet Healthcare, an estimated $200M.

By sector, the portfolio is most concentrated in Healthcare at 52% of assets, up from 43% a quarter earlier, followed by Technology and Industrials.

  • Glenview Capital Management's largest Q2 2024 buy was Centene: 1,431,312 shares worth $94.9M.
  • Glenview Capital Management added most to CVS Health in Q2 2024, an estimated $467M increase.
  • Glenview Capital Management's biggest Q2 2024 reduction was Tenet Healthcare, cutting an estimated $200M.
  • Glenview Capital Management fully exited Meta Platforms (Facebook) in Q2 2024, selling an estimated $53.1M.
  • Glenview Capital Management's ten largest holdings make up 63% of its $5.08B portfolio in Q2 2024.
  • Glenview Capital Management opened 9 new positions and closed 6 in Q2 2024.
  • Glenview Capital Management's portfolio value fell 11% quarter-over-quarter to $5.08B.

Based on Glenview Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.